Literature DB >> 24448744

The development of an automated and GMP compliant FASTlab™ Synthesis of [(18) F]GE-180; a radiotracer for imaging translocator protein (TSPO).

Torild Wickstrøm1, Alan Clarke, Ingvil Gausemel, Eric Horn, Karina Jørgensen, Imtiaz Khan, Dimitrios Mantzilas, Thanushan Rajanayagam, Dirk-Jan in 't Veld, William Trigg.   

Abstract

The level of the translocator protein (TSPO) increases dramatically in microglial cells when the cells are activated in response to neuronal injury and insult. The radiotracer [(18) F]GE-180 binds selectively and with high affinity to TSPO and can therefore be used to measure neuroinflammation in a variety of disease states. An optimized, automated synthesis of [(18) F]GE-180 has been developed for the GE FASTlab™ synthesizer. The entire process takes place on the single-use cassette. The radiolabelling is performed by nucleophilic fluorination of the S- enantiomer mesylate precursor. The crude product is purified post-radiolabelling using two solid-phase extraction cartridges integrated on the cassette. Experimental design and multivariate data analysis were used to assess the robustness, and critical steps were optimized with respect to efficacy and quality. The average radiochemical yield is 48% (RSD 6%, non-decay corrected), and the synthesis time including purification is approximately 43 min. The radiochemical purity is ≥95% for radioactive concentration ≤1100 MBq/mL. The total amount of precursor-related chemical impurities is 1-2 µg/mL. The use of solid-phase extraction purification results in a robust GMP compliant process with a product of high chemical and radiochemical purity and consistent performance across positron emission tomography (PET) centers.
Copyright © 2013 John Wiley & Sons, Ltd.

Entities:  

Keywords:  FASTlab; GE-180; PET tracer; TSPO; neuroinflammation; peripheral benzodiazepine receptor

Mesh:

Substances:

Year:  2013        PMID: 24448744     DOI: 10.1002/jlcr.3112

Source DB:  PubMed          Journal:  J Labelled Comp Radiopharm        ISSN: 0362-4803            Impact factor:   1.921


  29 in total

1.  TSPO PET, tumour grading and molecular genetics in histologically verified glioma: a correlative 18F-GE-180 PET study.

Authors:  M Unterrainer; D F Fleischmann; F Vettermann; V Ruf; L Kaiser; D Nelwan; S Lindner; M Brendel; V Wenter; S Stöcklein; J Herms; V M Milenkovic; R Rupprecht; J C Tonn; C Belka; P Bartenstein; M Niyazi; N L Albert
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-09-05       Impact factor: 9.236

2.  TSPO PET with [18F]GE-180 sensitively detects focal neuroinflammation in patients with relapsing-remitting multiple sclerosis.

Authors:  Marcus Unterrainer; C Mahler; L Vomacka; S Lindner; J Havla; M Brendel; G Böning; B Ertl-Wagner; T Kümpfel; V M Milenkovic; R Rupprecht; M Kerschensteiner; P Bartenstein; Nathalie L Albert
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-03-09       Impact factor: 9.236

3.  Differential Spatial Distribution of TSPO or Amino Acid PET Signal and MRI Contrast Enhancement in Gliomas.

Authors:  Lena Kaiser; Adrien Holzgreve; Stefanie Quach; Michael Ingrisch; Marcus Unterrainer; Franziska J Dekorsy; Simon Lindner; Viktoria Ruf; Julia Brosch-Lenz; Astrid Delker; Guido Böning; Bogdana Suchorska; Maximilian Niyazi; Christian H Wetzel; Markus J Riemenschneider; Sophia Stöcklein; Matthias Brendel; Rainer Rupprecht; Niklas Thon; Louisa von Baumgarten; Jörg-Christian Tonn; Peter Bartenstein; Sibylle Ziegler; Nathalie L Albert
Journal:  Cancers (Basel)       Date:  2021-12-23       Impact factor: 6.639

4.  Comparison of 18F-GE-180 and dynamic 18F-FET PET in high grade glioma: a double-tracer pilot study.

Authors:  Marcus Unterrainer; D F Fleischmann; C Diekmann; L Vomacka; S Lindner; F Vettermann; M Brendel; V Wenter; B Ertl-Wagner; J Herms; C Wetzel; R Rupprecht; J C Tonn; C Belka; P Bartenstein; M Niyazi; Nathalie L Albert
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-09-22       Impact factor: 9.236

5.  The FTD-like syndrome causing TREM2 T66M mutation impairs microglia function, brain perfusion, and glucose metabolism.

Authors:  Gernot Kleinberger; Matthias Brendel; Eva Mracsko; Benedikt Wefers; Linda Groeneweg; Xianyuan Xiang; Carola Focke; Maximilian Deußing; Marc Suárez-Calvet; Fargol Mazaheri; Samira Parhizkar; Nadine Pettkus; Wolfgang Wurst; Regina Feederle; Peter Bartenstein; Thomas Mueggler; Thomas Arzberger; Irene Knuesel; Axel Rominger; Christian Haass
Journal:  EMBO J       Date:  2017-05-30       Impact factor: 11.598

6.  In vivo PET imaging of the neuroinflammatory response in rat spinal cord injury using the TSPO tracer [(18)F]GE-180 and effect of docosahexaenoic acid.

Authors:  J L Tremoleda; O Thau-Zuchman; M Davies; J Foster; I Khan; K C Vadivelu; P K Yip; J Sosabowski; W Trigg; A T Michael-Titus
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-05-07       Impact factor: 9.236

7.  In Vivo Imaging of Glial Activation after Unilateral Labyrinthectomy in the Rat: A [18F]GE180-PET Study.

Authors:  Andreas Zwergal; Lisa Günther; Matthias Brendel; Roswitha Beck; Simon Lindner; Guoming Xiong; Eva Eilles; Marcus Unterrainer; Nathalie Lisa Albert; Sandra Becker-Bense; Thomas Brandt; Sibylle Ziegler; Christian la Fougère; Marianne Dieterich; Peter Bartenstein
Journal:  Front Neurol       Date:  2017-12-11       Impact factor: 4.003

8.  Impact of TSPO Receptor Polymorphism on [18F]GE-180 Binding in Healthy Brain and Pseudo-Reference Regions of Neurooncological and Neurodegenerative Disorders.

Authors:  Franziska J Vettermann; Stefanie Harris; Julia Schmitt; Marcus Unterrainer; Simon Lindner; Boris-Stephan Rauchmann; Carla Palleis; Endy Weidinger; Leonie Beyer; Florian Eckenweber; Sebastian Schuster; Gloria Biechele; Christian Ferschmann; Vladimir M Milenkovic; Christian H Wetzel; Rainer Rupprecht; Daniel Janowitz; Katharina Buerger; Robert Perneczky; Günter U Höglinger; Johannes Levin; Christian Haass; Joerg C Tonn; Maximilian Niyazi; Peter Bartenstein; Nathalie L Albert; Matthias Brendel
Journal:  Life (Basel)       Date:  2021-05-26

9.  In Vivo Detection of Age- and Disease-Related Increases in Neuroinflammation by 18F-GE180 TSPO MicroPET Imaging in Wild-Type and Alzheimer's Transgenic Mice.

Authors:  Bin Liu; Kevin X Le; Mi-Ae Park; Shuyan Wang; Anthony P Belanger; Shipra Dubey; Jeffrey L Frost; Peter Holton; Vladimir Reiser; Paul A Jones; William Trigg; Marcelo F Di Carli; Cynthia A Lemere
Journal:  J Neurosci       Date:  2015-11-25       Impact factor: 6.167

10.  Kinetic analysis of the translocator protein positron emission tomography ligand [18F]GE-180 in the human brain.

Authors:  Claire Feeney; Gregory Scott; Joel Raffel; S Roberts; Christopher Coello; Amy Jolly; Graham Searle; A P Goldstone; David J Brooks; Richard S Nicholas; William Trigg; Roger N Gunn; David J Sharp
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-06-28       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.